IGFBP6 and cancer: Among 6 genes that significantly decreased the survival rate of patients, TSD22D3 and IGFBP6 were up-regulated in our results but their expression in STAD patients was lower than in normal tissues, suggesting that CTLs exhibit cytotoxicity partially by down-regulating them in cancer cells.